Product Launch And AdoptionZUNVEYL rollout continues to advance with overwhelmingly positive feedback from prescribers and active prescriptions by healthcare practitioners.
Regulatory ProgressChinese regulatory submission accepted for review by the National Medical Products Administration, potentially leading to approval next year.
Sales And Financial PerformanceAlpha Cognition's sales exceeded expectations, leading to an increase in sales forecasts for the upcoming years.